Curative effect of DL-2-Difluoromethylornithine on Mice Bearing Mutant L1210 Leukemia Cells Deficient in Polyamine Uptake

Cancer Research

Volumn 48, Issue 17, 1988, Pages 4807-4811

  Persson, Lo ^a   Holm, Ingvar ^a   Ask, Anders ^a   Heby, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; POLYAMINE;

ANIMAL EXPERIMENT; CELL MUTANT; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; EFLORNITHINE; LEUKEMIA L1210; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MITOGUAZONE; MUTATION; POLYAMINES; SUPPORT, NON-U.S. GOV'T;

EID: 0023719337     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pegg, A. E., and McCann, P. P. Polyamine metabolism and function. Am. J. Physiol., 243.-C212-C221, 1982.
2. Pegg, A. E. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J., 234: 249-262, 1986.
3. Heby, O., Luk, G. D., and Schindler, J. Polyamine synthesis inhibitors act as both inducers and suppressors of cell differentiation, hi: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.). Inhibition of Polyamine Metabolism, pp. 165-186. New York: Academic Press, 1987.
4. Metcalf, B. W., Bey, P., Danzin, C., Jung, M., Casara, P., and Vevert, J. P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (EC4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc., 100:2551-2553, 1978.
5. Heby, O., and Janne, J. Polyamine antimetabolites: Biochemistry, specificity, and biological effects of inhibitors of polyamine synthesis. In: D. R. Morris and L. J. Marlon (eds.), Polyamines in Biology and Medicine, pp. 243-310.New York: Mercel Dekker, 1981.
6. Sjoerdsma, A., and Schechter, P. J. Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin. Pharmacol. Ther., 35: 287-300, 1984.
7. Sjoerdsma, A., Golden, J. A., Schechter, P. J., Barlow, J. L. R., and Santi, D. V. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, a-difluoromethylornithine. Trans. Assoc. Am. Physicians, 97: 70-79, 1984.
8. Golden, J. A., Sjoerdsma, A., and Santi, D. V. Pneumocystis carinii pneumonia treated with a-difluoromethylornithine. Clin. Invest., 141: 613-623, 1984.
9. Ask, A., Persson, L., Oredsson, S. M., and Heby, O. Synergistic antileukemic effect of two polyamine synthesis inhibitors. Host survival and cell-cyclekinetic analysis. Int. J. Cancer, 37:465-470, 1986.
10. Kubota, S., Oshawa, N., and Takaku, F. Effects of DL-α-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo. Int. J. Cancer, 59:244-247, 1987.
11. Mamont, P. S., Duchesne, M. C., Grove, J., and Bey, P. Ami-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem. Biophys. Res. Commun., 81: 58-66, 1978.
12. Sinikara, P. S., Chang, C. C., Prakash, N. J., and Lachmann, P. J. Effect of inhibition of polyamine biosynthesis by DL-a-difiuoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo. Cancer Res., 45:4067-4070. 1985.
13. Erwin, B. G., and Pegg, A. E. Uptake, of a-difluoromethylornithine by mouse fibroblasts. Biochem. Pharmacol., 31: 2820-2823, 1982.
14. Grove, J., Fozard, J. R., and Mamont, P. S. Assay of α-difluoromethylorni thine in body fluids and tissues by automatic amino acid analysis. J. Chromatogr., 223:409-416, 1981.
15. Russell, D. H., and Snyder, S. H. Amine synthesis in regenerating rat liver. Extremely rapid turnover of ornithine decarboxylase. Mol. Pharmacol., 5:253-262, 1969.
16. Persson, L., Oredsson, S. M., Anehus, S., and Heby, O. Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: Implications for translational regulation. Biochem. Biophys. Res. Commun., 131: 239-245,1985.
17. Persson, L., Holm, I., and Heby, O. Translational regulation of ornithine decarboxylase by polyamines. FEBS Lett., 205:175-178, 1986.
18. Miirahaia. A., and Pegg, A. E. Increased content of mRNA for a precursor of 5-adenosylmethionine decarboxylase in rat prostate after treatment with 2-difluoromethylornithine. J. Biol. Chem., 261:13833-13837,1986.
19. Alhonen-Hongisto, L., Seppanen, P., and Janne, J. Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone). Biochem. J., 192: 941-945, 1980.
20. Seppanen, P. Some properties of the polyamine deprivation-inducible uptake system for methylglyoxal bis(guanylhydrazone) in tumor cells. Acta Chem. Scand., B35:731-736,1981.
21. Heston, W. D. W., Kadmon, D., Covey, D. F., and Fair, W. R. Differential effect of a-difluoromethylornithine on the in vivo uptake of MC-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor. Cancer Res., 44: 1034-1040, 1984.
22. Cooper, K. D., Shukla, J. B., and Owen, M. R. Polyamine compartmentalization in various human disease states. Clin. Chim. Acta, 82: 1-7, 1978.
23. Lundgren. D. W., and Oka, T. Alterations in polyamine levels in rat blood during pregnancy and lactation. Am. J. Physiol., 234: E451-E456, 1978.
24. Claverie, N., Wagner, J., Knödgen,B., and Seiler, N. Inhibition of polyamine oxidase improves the amitumoral effect of ornithine decarboxylase inhibitors. Anticancer Res., 7: 765-772, 1987.
25. Mandel, J.-L., and Flintoff, W. F. Isolation of mutant mammalian cells altered in polyamine transport. J. Cell. Physiol., 97:335-344, 1978.
26. Field, M., Block, J. B., Oliverio, V. T., and Rail, D. P. Cellular accumulation of methylglyoxal-bis-guanylhydrazone in viiro. I. General characteristics of cellular uptake. Cancer Res., 24: 1939-1946, 1964.
27. Mihich, E. L., Dave, C., and Williams-Ashman, H. G. Antiproliferative actions of the antileukemic agent methylglyoxal bis(guanylhydrazone): Relationships to spermidine. Prog. Chemother. Proc. Int. Congr. Chemother. 8th Athens 1974, pp. 845-848.
28. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
29. Mihich, E., and Kitano, M. Differences in the immunogenicity of leukemia LI210 sublines in DBA/2 mice. Cancer Res., 31: 1999-2003, 1971.
30. Kitano, M., Mihich, E., and Pressman, D. Antigenic differences between eukemia L1210 and a subline resistant to methylglyoxal-bis (guanylhydrazone). Cancer Res., 32: 181-186, 1972.
31. Kano, K., and Oka, T. Polyamine transport and metabolism in mouse mammary gland. J. Biol. Chem., 251: 2795-2800, 1976.
32. Porter, C. W., Miller, J., and Bergeron, R. J. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia ce,l, Cancer Res., 44: 126-128, 1984.
33. Feige, J. J., and Chambaz, E. M. Polyamine uptake by bovine adrenocortical cells. Biochim. Biophys. Acta, 846: 93-100, 1985.
34. Wiseman, A., Kramer, D. L., and Porter, C. W. Isolation and uptake characteristics of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone). Cancer Res., 43: 5937-5942, 1983.
35. Pegg, A. E., Erwin, B. G., and Persson, L. Induction of spermidine/spermine N1-acetyltransferase by methylglyoxal bis(guanylhydrazone). Biochim. Biophys. Acta, 842: 111-118, 1985.
36. Shirahata, A., and Pegg, A. E. Regulation of 5-adenosylmethionine decarboxylase activity in rat liver and prostate. J. Biol. Chem., 260: 9583-9588,1985.
37. Sircar, S., Palkonyay, L., Rodrigues, M., Allaire, S., Horvath, J., Thinon, J-.P., and Weber, J. Isolation of variants resistant to methylglyoxal bis(gunylhydrazone) from adenovirus-transformed rat cells. Cancer Res., 47:1339-1343, 1987.
38. Rodrigues, M. T., Palkonyay,L., Sircar, S., Fleurent, J., Dessureault, J., and Weber, J. M. Isolation and uptake characteristics of adenovirus transformed cell revenants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone). Biochem. Biophys. Res. Commun., 147: 675-681, 1987.